Leuprolide Completed Phase 1 Trials for Postmenopausal Disorder Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03233932CKD-841 Pharmacokinetic/Pharmacodynamic Study